Phase II study in adults with untreated acute lymphoblastic leukemia testing increased doses of daunorubicin during induction, and cytarabine during consolidation, followed by high-dose methotrexate and intrathecal methotrexate in place of cranial irradiation.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Folinic acid; Folinic acid; Mercaptopurine; Methotrexate; Prednisone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 06 Jul 2016 Biomarkers information updated
- 10 Apr 2012 Planned end date (1 Jan 2013) added as reported by Clinicaltrials.gov record.
- 01 Apr 2011 Status changed from completed to active, no longer recruiting, according to Clinicaltrials.gov.